BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH PSORIASIS IN THE ITALIAN SETTING

被引：0

作者：

Barbieri, M. ^{[1
]}

Capri, S. ^{[2
]}

Oskar, B. ^{[3
]}

机构：

[1] Univ York, Ctr Hlth Econ, York, N Yorkshire, England

[2] Cattaneo LIUC Univ, Sch Econ & Management, Castellanza, Italy

[3] Celgene Corp, Milan, Italy

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 07期

关键词：

D O I：

10.1016/j.jval.2015.09.560

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSS36

引用

下载

页码：A421 / A421

页数：1

共 50 条

[31] Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
Avgerinou, Georgia
Bassukas, Ioannis
Chaidemenos, Georgios
Katsampas, Andreas
Kosmadaki, Marita
Kousoulakou, Hara
Petridis, Athanasios
Schenkel, Brad
Sotiriadis, Dimitrios
Spiliopoulos, Theofanis
Stavropoulos, Panagiotis
Toumpi, Evgenia
Xaplanteris, Loukas
BMC DERMATOLOGY, 2012, 12
[32] Comparative analysis of apremilast in palmoplantar psoriasis and palmoplantar pustulosis
Spencer, Riley
Elhage, Kareem
Jin, Joy
Davis, Mitchell
Hakimi, Marwa
Bhutani-Jacques, Tina
Liao, Wilson
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB138 - AB138
[33] BUDGET IMPACT ANALYSIS OF DEEP BRAIN STIMULATION FOR THE TREATMENT OF PARKINSON'S DISEASE PATIENTS IN THE ITALIAN
Straziota
VALUE IN HEALTH, 2017, 20 (09) : A576 - A576
[34] SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone
Ahmed, S. M. A.
Volonte, M.
Isoletta, E.
Vassallo, C.
Tomasini, C. F.
Lilleri, D.
Zelini, P.
Musella, V.
Klersy, C.
Brazzelli, V.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) : E86 - E88
[35] Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
Graier, Thomas
Weger, Wolfgang
Sator, Paul-Gunther
Salmhofer, Wolfgang
Gruber, Barbara
Jonak, Constanze
Koelli, Claudia
Schuetz-Bergmayr, Martina
Vujic, Igor
Ratzinger, Gudrun
Haering, Nina
Painsi, Clemens
Prillinger, Knut
Mlynek, Alexander
Skvara, Hans
Trattner, Hannes
Rudolfstiftung, Vienna
Tanew, Adrian
Lichem, Roland
Ellersdorfer, Christina
Legat, Franz
Gruber-Wackernagel, Alexandra
Hofer, Angelika
Schmiedberger, Erich
Hoetzenecker, Wolfram
Muellegger, Robert
Saxinger, Werner
Quehenberger, Franz
Wolf, Peter
JAAD INTERNATIONAL, 2021, 2 : 62 - 75
[36] Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis
Cortesi, Paolo Angelo
Antonazzo, Ippazio Cosimo
Palladino, Pasquale
Gnesi, Marco
Mele, Silvia
D'Amelio, Marco
Ferrari, Elena Zanzottera
Mazzaglia, Giampiero
Mantovani, Lorenzo Giovanni
ACTA DIABETOLOGICA, 2024, 61 (08) : 1017 - 1028
[37] Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Verus the In-person Setting During the COVID-19 Pandemic
Das, Ashis K. K.
Chang, Eunice
Paydar, Caleb
Broder, Michael S. S.
Orroth, Kate K. K.
Cordey, Myriam
DERMATOLOGY AND THERAPY, 2023, 13 (09) : 1973 - 1984
[38] Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
Ashis K. Das
Eunice Chang
Caleb Paydar
Michael S. Broder
Kate K. Orroth
Myriam Cordey
Dermatology and Therapy, 2023, 13 : 1973 - 1984
[39] Association analysis of the loricrin gene in Italian patients with psoriasis
Giardina, E
Capon, F
Tacconelli, A
Chimenti, S
Zambruno, G
Novelli, G
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 74 - 74
[40] Adverse events associated with apremilast use and withdrawal for psoriasis in a real-world setting
Lee, E. B.
Amin, M.
Egeberg, A.
Wu, J. J.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : E393 - E394

← 1 2 3 4 5 →